Viewing data from:

SOTALOL HYDROCHLORIDE

ANDA

SOTALOL HYDROCHLORIDE | A076214 | APOTEX INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: BETAPACE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.1351

per ea

Lowest NADAC/Unit

$0.0695

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
60505022401SOTALOL AF 160 MG TABLET	$0.1351	EA	Generic	—	2026-08-19
60505022301SOTALOL AF 120 MG TABLET	$0.1106	EA	Generic	—	2026-08-19
60505022201SOTALOL AF 80 MG TABLET	$0.0695	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$34.52

Highest Price

$57.40

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
60505-0222-01SOTALOL HCL 80MG TAB	$34.52	FSS	Golden State Medical Supply, Inc.	06/14/2028
60505-0223-01SOTALOL HCL 120MG TAB	$45.38	FSS	Golden State Medical Supply, Inc.	06/14/2028
60505-0224-01SOTALOL HCL 160MG TAB	$57.40	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain2 active DMFs5 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SIEGFRIED LTDSOTALOL HYDROCHLORIDE

DMF 37211980

NEULAND LABORATORIES LTDSOTALOL HYDROCHLORIDE USP

DMF 149512000

IROTEC LABORATORIESInactiveSOTALOL HYDROCHLORIDE

DMF 118871996

ERREGIERRE SPAInactiveSOTALOL HYDROCHLORIDE

DMF 130831998

HEUMANN PHARMA GMBHInactiveSOTALOL HYDROCHLORIDE

DMF 131861998

SIFAVITOR SRLInactiveSOTALOL HYDROCHLORIDE

DMF 148412000

AREVIPHARMA GMBHInactiveSOTALOL HYDROCHLORIDE

DMF 237522010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 80MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 27, 2003

No patent or exclusivity listings for this strength.

#002 — 120MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 27, 2003

#003 — 160MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 27, 2003